C. Zhou

1.4k total citations · 1 hit paper
50 papers, 660 citations indexed

About

C. Zhou is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, C. Zhou has authored 50 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 33 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in C. Zhou's work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (13 papers) and Colorectal Cancer Treatments and Studies (11 papers). C. Zhou is often cited by papers focused on Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Research Studies (13 papers) and Colorectal Cancer Treatments and Studies (11 papers). C. Zhou collaborates with scholars based in China, United States and South Korea. C. Zhou's co-authors include Yuri Rukazenkov, Byoung Chul Cho, Fumio Imamura, Riyaz Shah, Meng‐Chih Lin, Suresh S. Ramalingam, J. Carl Barrett, Margarita Majem, Juliann Chmielecki and Aleksandra Markovets and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

C. Zhou

44 papers receiving 651 citations

Hit Papers

Mechanisms of acquired resistance to first-line osimertin... 2018 2026 2020 2023 2018 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study
    2018 269 citations Suresh S. Ramalingam, C. Zhou et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Zhou China 9 551 449 202 153 47 50 660
Tzu‐Hsiu Tsai Taiwan 13 471 0.9× 372 0.8× 183 0.9× 178 1.2× 48 1.0× 17 611
Chiara Bennati Italy 13 502 0.9× 406 0.9× 180 0.9× 158 1.0× 72 1.5× 40 632
Anna Squadrilli Italy 11 394 0.7× 392 0.9× 220 1.1× 127 0.8× 37 0.8× 17 560
Rinat Galiulin United States 6 388 0.7× 370 0.8× 135 0.7× 110 0.7× 39 0.8× 7 556
R. McCormack United Kingdom 7 396 0.7× 285 0.6× 120 0.6× 213 1.4× 42 0.9× 10 500
Minhao Fan China 6 268 0.5× 305 0.7× 175 0.9× 134 0.9× 55 1.2× 11 531
Annamaria Siggillino Italy 13 324 0.6× 256 0.6× 274 1.4× 138 0.9× 53 1.1× 24 514
Bin-Chi Liao Taiwan 15 561 1.0× 553 1.2× 217 1.1× 118 0.8× 39 0.8× 36 791
Eamon M. Berge United States 8 425 0.8× 303 0.7× 231 1.1× 141 0.9× 41 0.9× 14 540
Lorin A. Ferris United States 8 512 0.9× 383 0.9× 250 1.2× 159 1.0× 70 1.5× 10 616

Countries citing papers authored by C. Zhou

Since Specialization
Citations

This map shows the geographic impact of C. Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Zhou more than expected).

Fields of papers citing papers by C. Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Zhou. The network helps show where C. Zhou may publish in the future.

Co-authorship network of co-authors of C. Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of C. Zhou. A scholar is included among the top collaborators of C. Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Zhou. C. Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Chenhui, et al.. (2025). Exploration of the Mountainous Urban Rail Transit Resilience Under Extreme Rainfalls: A Case Study in Chongqing, China. Applied Sciences. 15(2). 735–735. 1 indexed citations
2.
3.
Huang, Xiaowen, Jilin Wang, C. Zhou, et al.. (2023). Metformin Reprograms Tryptophan Metabolism to Stimulate CD8+ T-cell Function in Colorectal Cancer. Cancer Research. 83(14). 2358–2371. 58 indexed citations
4.
Yang, James Chih‐Hsin, Paul Mitchell, Thomas John, et al.. (2023). 1325P Sunvozertinib as first-line treatment in NSCLC patients with EGFR Exon20 insertion mutations. Annals of Oncology. 34. S765–S765. 7 indexed citations
5.
He, Yuan, et al.. (2021). P47.13 Galectin-9, A Novel Prognostic Factor in Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(3). S498–S498. 2 indexed citations
6.
7.
Zhou, C., Meghna Das Thakur, Manoj Srivastava, et al.. (2021). 2O IMpower010: Biomarkers of disease-free survival (DFS) in a phase III study of atezolizumab (atezo) vs best supportive care (BSC) after adjuvant chemotherapy in stage IB-IIIA NSCLC. Annals of Oncology. 32. S1374–S1374. 41 indexed citations
8.
Liao, Wei‐Yu, Jing‐Na Lin, Huan Jia, et al.. (2020). Resistance and Heteroresistance to Colistin in Escherichia coli Isolates from Wenzhou, China. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Mao, Shiqi, Yanbiao Liu, Fei Zhou, et al.. (2019). P1.01-62 Association of Baseline Pulmonary Fibrosis with the Outcome of PD-1 Inhibitor in Patients with Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S383–S383. 1 indexed citations
10.
Zheng, Huiyuan, C. Zhou, Xiao Lu, et al.. (2018). DJ-1 promotes survival of human colon cancer cells under hypoxia by modulating HIF-1α expression through the PI3K-AKT pathway. SHILAP Revista de lepidopterología. 2 indexed citations
11.
He, Yayi, C. Zhou, & W. Hirsch. (2018). P2.11-08 Tumor Autoantibody Panel Can Improve the Accuracy of Early Diagnosis in Lung Cancer Presenting with GGNs /Solid Nodules. Journal of Thoracic Oncology. 13(10). S781–S782. 1 indexed citations
12.
Zhou, C., Xiaofan Zhu, Yihua Sun, et al.. (2018). OA10.07 Resistance Mechanisms of Osimertinib in Chinese Non-Small Cell Lung Cancer patients: Analysis from AURA17 Trial. Journal of Thoracic Oncology. 13(10). S345–S345. 6 indexed citations
13.
Zhou, C., Ying Cheng, You Lü, et al.. (2017). CNS response to osimertinib in Asian-Pacific patients (pts) with T790M-positive advanced NSCLC: data from an open-label Phase II trial (AURA17). Annals of Oncology. 28. v484–v484. 5 indexed citations
14.
15.
Ohe, Yuichiro, Suresh S. Ramalingam, Thanyanan Reungwetwattana, et al.. (2017). Osimertinib vs standard of care EGFR-TKI as first-line treatment in patients with EGFRm advanced NSCLC: FLAURA. Annals of Oncology. 28. x125–x125. 1 indexed citations
16.
Karachaliou, Niki, Imane Chaib, Sara Pilotto, et al.. (2016). 76P An innovative co-targeting of signal transducer and activator of transcription 3 (STAT3) and Src-YAP pathways in EGFR mutant non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 11(4). S87–S88. 1 indexed citations
17.
Hou, Lili, et al.. (2016). 53P Transcutaneous electrical acupoint stimulation ameliorates chemotherapy-induced bone marrow suppression in lung cancer patients. Journal of Thoracic Oncology. 11(4). S77–S77. 1 indexed citations
18.
Gong, Xiaonan, et al.. (2016). 81P Radiation resistance induced immunity evasion by evoking PD-L1 expression. Journal of Thoracic Oncology. 11(4). S89–S90. 5 indexed citations
19.
20.
Su, Chunxia, Lihong Fan, Li-Mou Zheng, et al.. (2013). ROS1 fusions in Chinese patients with non-small-cell lung cancer. Annals of Oncology. 24(7). 1822–1827. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tzu‐Hsiu Tsai Breakdown of academic impact, for papers by Chiara Bennati Breakdown of academic impact, for papers by Anna Squadrilli Breakdown of academic impact, for papers by Rinat Galiulin Breakdown of academic impact, for papers by R. McCormack Breakdown of academic impact, for papers by Minhao Fan Breakdown of academic impact, for papers by Annamaria Siggillino Breakdown of academic impact, for papers by Bin-Chi Liao Breakdown of academic impact, for papers by Eamon M. Berge Breakdown of academic impact, for papers by Lorin A. Ferris
Rankless by CCL
2026